Cargando…
Therapeutic strategies to overcome ALK resistance in cancer /
"Therapeutic Strategies to Overcome ALK Resistance in Cancer, Volume 13, presents current strategies to improve and prolong clinical benefit in ALK driven cancers. Most patients with ALK-driven cancer are sensitive to tyrosine kinase inhibitor (TKI) therapy, but resistance invariably develops....
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London, United Kingdom :
Academic Press, an imprint of Elsevier,
[2021]
|
| Colección: | Cancer sensitizing agents for chemotherapy ;
v. 13. |
| Temas: | |
| Acceso en línea: | Texto completo |